Protein | Gene Symbol | All allelic disease phenotypes - locus/disease symbols |
| maspardin | |  * Spastic paraplegia 20 - SPG21 (15.26)
|
matrin 3 | | * Myopathy, distal 2 - MPD2 (4.5)
| mediator complex subunit 25 | | * Charcot-Marie-Tooth disease, type 2B2 - CMT2B2 (14.52)
| member RAS oncogene family | | * Charcot-Marie-Tooth neuropathy Type 2B - CMT2B (14.37)
| microsomal triglyceride transfer protein | | * abetalipoproteinemia - ABL (13.57)
| mitochondrial carrier; adenine nucleotide translocator | | * Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal - PEOA2 (16.17)
| mitochondrial DNA polymerase, accessory subunit | | * progressive external ophthalmoplegia, autosomal dominant, 4 - PEOA4 (16.19)
| mitochondrial dynamin-like GTPase | | * optic atrophy 1 and deafness - (16.24)
| mitochondrial ribosomal protein L3 | | * Hypertrophic mitochondrial cardiomyopathy with MRPL3 defect - (10.25)
| mitofusin 2 | | * Hereditary motor and sensory neuropathy 2A - CMT2A (14.36)
| MRE11 meiotic recombination 11 homolog A | | * ataxia telangiectasia-like disorder - ATLD (13.53)
| muscle-related coiled-coil protein | | * Dilated cardiomyopathy with MURC defect - (10.65)
| myelin protein zero | | * Charcot-Marie-Tooth disease, type 1B - CMT1B (14.2, 14.14, 14.21, 14.32, 14.44, 14.45)
* Dejerine-Sottas syndrome - DSSA (14.2, 14.14, 14.21, 14.32, 14.44, 14.45)
* Neuropathy, congenital hypomyelinating - CMT4E (14.2, 14.14, 14.21, 14.32, 14.44, 14.45)
* Charcot-Marie-Tooth disease, type 2I - CMT2I (14.2, 14.14, 14.21, 14.32, 14.44, 14.45)
* Charcot-Marie-Tooth disease, type 2J - CMT2J (14.2, 14.14, 14.21, 14.32, 14.44, 14.45)
* Charcot-Marie-Tooth disease, dominant intermediate D - CMTDID (14.2, 14.14, 14.21, 14.32, 14.44, 14.45)
| myopalladin | | * Dilated cardiomyopathy due to myopalladin defect - (10.58)
| myosin heavy chain 6 | | * Cardiomyopathy, familial hypertrophic 1 - CMH1 (10.1, 10.13, 10.62)
* Familial hypertrophic cardiomyopathy, 14 - CMH14 (10.1, 10.13, 10.62)
* Cardiomyopathy, dilated, 1EE - CMD1EE (10.1, 10.13, 10.62)
| Myosin heavy chain, 8, skeletal muscle, perinatal | | * Myosin, heavy chain, perinatal - MYH8 (16.15)
| myosin light chain 2 | | * Cardiomyopathy, hypertrophic, mid-left ventricular chamber type - MYL2 (10.9)
* Cardiomyopathy, familial hypertrophic, 10 - CMH10 (10.9)
| myosin light chain 3 | | * Cardiomopathy, hypertrophic, mid-ventricular chamber type - MYL3 (10.7)
| myosin light chain kinase 2 | | * cardiomyopathy, familial hypertrophic - CMH (10.15)
| myosin, heavy polypeptide 2, skeletal muscle | | * Myopathy with joint contractures, ophtalmoplegia, and rimmed vacuoles - IBM3 (3.25, 3.26)
| myosin, heavy polypeptide 7, cardiac muscle, beta | | * Myopathy, distal 1 - MPD1 (3.13, 3.23, 3.24, 4.4, 10.1, 10.45)
* cardiomyopathy, familial hypertrophic, 1, included - CMH1 (3.13, 3.23, 3.24, 4.4, 10.1, 10.45)
* myopathy, congenital, with fiber-type disproportion - CFTD (3.13, 3.23, 3.24, 4.4, 10.1, 10.45)
* Myosin storage myopathy - (3.13, 3.23, 3.24, 4.4, 10.1, 10.45)
* Cardiomyopathy, dilated, 1S - CMD1S (3.13, 3.23, 3.24, 4.4, 10.1, 10.45)
| myosine, heavy chain 3, skeletal muscle, embryonic | | * Arthrogryposis, distal, type 2A - DA2A (16.9, 16.12)
* Arthrogryposis, distal, type 2B - DA2B (16.9, 16.12)
| myostatin, muscular hypertrophy | | * Muscle hypertrophy - MSLHP (5.15)
| myotilin | | * Muscular dystrophy, Limb-Girdle, type 1A - LGMD1A (1.11, 4.9, 5.6, 5.7)
* Spheroid body myopathy - (1.11, 4.9, 5.6, 5.7)
* Myofibrillar myopathy, myotilin related - MFM3 (1.11, 4.9, 5.6, 5.7)
| myotonic dystrophy protein kinase | | * Steinert disease - DM1 (6.1)
* Myotonic dystrophy 1 - DM1 (6.1)
* Dystrophia myotonica - DM (6.1)
| myotubularin | | * Myotubular myopathy, X-linked - MTM1 (3.14)
| myotubularin-related protein 2 | | * Charcot-Marie-Tooth disease, type 4B1 - CMT4B1 (14.16)
| myozenin 2, or calsarcin 1, a Z disk protein | | * Hypertrophic cardiomyopathy with myozenin 2 defect - (10.18)
* Cardiomyopathy, familial hypertrophic, 16 - CMH16 - CMH16 (10.18)
|
